"Transforming cancer diagnostics with AI-powered models, a comprehensive pathology IT system, and remote consultation services with expert pathologists."
Explore Our SolutionsDPath is a Singapore-based company revolutionizing cancer diagnostics through decentralized AI solutions. Our platform empowers pathologists with advanced AI tools, a streamlined pathology IT system, and remote consultation services to improve diagnostic accuracy and efficiency, ensuring better patient outcomes.
By 2030, we aim to partner with over 1,000 hospitals and labs worldwide, providing AI-driven diagnostics for multiple cancer types. Our technology has already demonstrated 98% diagnostic concordance in external validation studies.
The DPath team comprises AI/ML experts from Carnegie Mellon University and the University of Toronto, alongside medical professionals from Johns Hopkins Hospital and Toronto General Hospital.
Our advanced AI models are trained on millions of pathology slides, delivering 98% diagnostic concordance for multiple cancer types, including prostate, breast, and lung cancer.
A comprehensive IT system designed to streamline pathology workflows, improve efficiency, and ensure seamless data integration across hospitals and labs.
Access expert-level pathologists for second opinions and consultations, enabling faster and more accurate diagnoses, regardless of geographic location.
End-to-end development of diagnostic AI models with federated evaluation and bias auditing, ensuring high accuracy and reliability.
Seamless integration of our Pathology IT System with existing hospital and lab systems, ensuring smooth workflows and data interoperability.
Comprehensive training and 24/7 support for hospitals and labs adopting our AI models, Pathology IT System, and Remote Consultation Service.
DPath NFTs represent ownership of synthetic pathology data, enabling secure contribution and fair compensation through smart contracts. Our innovative system ensures hospitals retain full data ownership while participating in global AI development.
Generate and own synthetic NFTs from local data while maintaining 100% raw data ownership and earning 50% of NFT royalties.
Expert pathologists earn 10% NFT royalties plus rewards for high-quality annotations of synthetic datasets.
Build AI models on synthetic NFT datasets with 30% model ownership, while 70% benefits NFT contributors.